U.S. Physical Therapy (NYSE:USPH) reports strong Q3 2026

What happened

U.S. Physical Therapy reported Q3 2026 revenue of $222.6 million, up 12.9% from a year earlier and above analysts’ $214.3 million estimate. Adjusted profit was $0.80 per share, also above estimates, while operating margin fell to 11.3% from 12.8%.

Confirmed

Global impact / market context

Revenue and adjusted profit beating estimates point to stronger-than-expected quarterly performance, while the lower operating margin shows the company kept less from each dollar of revenue than a year earlier. That combination matters because continued revenue growth may not translate into improving operating returns if costs rise faster.

Analyst inference

The article reports that sales volumes grew 8.3%, slower than the 18% growth recorded in the same quarter last year. Full-year EBITDA guidance, a measure of operating earnings before interest, taxes, depreciation and amortization, remained in line with analyst expectations at a $104 million midpoint.

Confirmed

What to watch

1. Compare future revenue growth with sales-volume growth to see whether higher revenue reflects more therapy visits or other factors; the article does not explain the difference. Analyst inference
2. Watch operating margin in later reports: a continued decline could mean operating costs are absorbing more of each revenue dollar despite sales growth. Analyst inference
3. Check whether the completed rollout of the first two hospital affiliations continues to contribute to EBITDA improvement, as the chief executive said it initially had. Confirmed

Evidence

• stockstory.org